BioAlliance appoints Pierre Morgon chief operating officer
This article was originally published in Scrip
Executive Summary
BioAlliance Pharma (France), a speciality pharmaceutical company focused on the treatment of infections in cancer and HIV, has strengthened its management board with the appointment of Pierre Morgon as chief operating officer. He joins from Schering-Plough France, where he managed primary care operations in France for two years and the partnership with MSD. From 2004 to 2006, Mr Morgon was vice-president of hospital operations at Bristol-Myers Squibb, and from 2003 to 2004 he served as general manager of Yamanouchi Pharma France.